4.6 Article

Understanding and responding to COVID-19 in Wales: protocol for a privacy-protecting data platform for enhanced epidemiology and evaluation of interventions

期刊

BMJ OPEN
卷 10, 期 10, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2020-043010

关键词

COVID-19; epidemiology; public health; health informatics

资金

  1. Health Data Research UK [HDR-9006]
  2. Medical Research Council [MR/V028367/1, MR/S027750/1]
  3. UK Medical Research Council
  4. Engineering and Physical Sciences Research Council
  5. Economic and Social Research Council
  6. National Institute for Health Research (England)
  7. Chief Scientist Office of the Scottish Government Health and Social Care Directorates
  8. Health and Social Care Research and Development Division (Welsh Government)
  9. Public Health Agency (Northern Ireland)
  10. British Heart Foundation
  11. Wellcome
  12. ESRC [ES/S007393/1] Funding Source: UKRI
  13. MRC [MR/S027750/1, MR/V028367/1] Funding Source: UKRI

向作者/读者索取更多资源

Introduction The emergence of the novel respiratory SARS-CoV-2 and subsequent COVID-19 pandemic have required rapid assimilation of population-level data to understand and control the spread of infection in the general and vulnerable populations. Rapid analyses are needed to inform policy development and target interventions to at-risk groups to prevent serious health outcomes. We aim to provide an accessible research platform to determine demographic, socioeconomic and clinical risk factors for infection, morbidity and mortality of COVID-19, to measure the impact of COVID-19 on healthcare utilisation and long-term health, and to enable the evaluation of natural experiments of policy interventions. Methods and analysis Two privacy-protecting population-level cohorts have been created and derived from multisourced demographic and healthcare data. The C20 cohort consists of 3.2 million people in Wales on the 1 January 2020 with follow-up until 31 May 2020. The complete cohort dataset will be updated monthly with some individual datasets available daily. The C16 cohort consists of 3 million people in Wales on the 1 January 2016 with follow-up to 31 December 2019. C16 is designed as a counterfactual cohort to provide contextual comparative population data on disease, health service utilisation and mortality. Study outcomes will: (a) characterise the epidemiology of COVID-19, (b) assess socioeconomic and demographic influences on infection and outcomes, (c) measure the impact of COVID-19 on short -term and longer-term population outcomes and (d) undertake studies on the transmission and spatial spread of infection. Ethics and dissemination The Secure Anonymised Information Linkage-independent Information Governance Review Panel has approved this study. The study findings will be presented to policy groups, public meetings, national and international conferences, and published in peer-reviewed journals.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据